According to FutureWise analysis the market for adams-oliver syndrome is expected to register a CAGR of 6.22% from 2023-2031. Adams–Oliver syndrome (AOS) is a rare congenital disorder defined by a distinct combination of features, including scalp and skull defects, which are classified as cutis aplasia congenita, transverse limb defects, and mottled skin. The manifestations of AOS...